Diamantopoulos, P.T.; Kontandreopoulou, C.-N.; Stafylidis, C.; Vlachopoulou, D.; Smilakou, S.; Patsialos, I.; Syriopoulou, S.; Gkikas, A.; Athanasopoulos, E.N.; Vogiatzakis, A.;
et al. Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma. Vaccines 2024, 12, 1216.
https://doi.org/10.3390/vaccines12111216
AMA Style
Diamantopoulos PT, Kontandreopoulou C-N, Stafylidis C, Vlachopoulou D, Smilakou S, Patsialos I, Syriopoulou S, Gkikas A, Athanasopoulos EN, Vogiatzakis A,
et al. Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma. Vaccines. 2024; 12(11):1216.
https://doi.org/10.3390/vaccines12111216
Chicago/Turabian Style
Diamantopoulos, Panagiotis T., Christina-Nefeli Kontandreopoulou, Christos Stafylidis, Dimitra Vlachopoulou, Stavroula Smilakou, Iraklis Patsialos, Stavroula Syriopoulou, Alexandros Gkikas, Eleftherios N. Athanasopoulos, Anastasios Vogiatzakis,
and et al. 2024. "Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma" Vaccines 12, no. 11: 1216.
https://doi.org/10.3390/vaccines12111216
APA Style
Diamantopoulos, P. T., Kontandreopoulou, C.-N., Stafylidis, C., Vlachopoulou, D., Smilakou, S., Patsialos, I., Syriopoulou, S., Gkikas, A., Athanasopoulos, E. N., Vogiatzakis, A., Panousi, E., Kyriakakis, G., Anastasopoulou, A., Mantzourani, M., & Labropoulou, V.
(2024). Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma. Vaccines, 12(11), 1216.
https://doi.org/10.3390/vaccines12111216